期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

即时血浆脑钠肽检测对心力衰竭的诊断价值 被引量：1

下载PDF
导出
摘要 心力衰竭是常见的心血管疾病，3年病死率约为60％，因心力衰竭住院的患者在以后12周内再住院或死亡的发生率为25％。在较短时间内对心力衰竭患者作出正确的诊断十分重要，本研究旨在探讨血浆脑钠肽（BNP）检测在心力衰竭诊断中的价值。
作者 孙立民 金美玲 曾军 王一波 沈卫峰
机构地区 上海市黄浦区中心医院心内科 上海交通大学医学院附属瑞金医院心内科
出处 《上海医学》 CAS CSCD 北大核心 2007年第4期284-285,共2页 Shanghai Medical Journal
关键词 心力衰竭患者 血浆脑钠肽 诊断价值 检测 心血管疾病 年病死率 再住院 发生率
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献12

  • 1沈卫峰.缺血性心力衰竭的研究现况[J].国际心血管病杂志,2006,33(1):1-4. 被引量：10
  • 2Collins SP,Ronan-Bentle S,Storrow AB.Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea.Ann Emerg Med,2003,41:532-545.
  • 3EugeneB.心脏病学.第5版.陈灏珠,译.北京:人民卫生出版社,2001:407.
  • 4Mukoyama M,Nakao K,Hosoda K,et al.Brain natriuretic peptide as a novel cardiac hormone in humans.Evidence for an exquisite dual natriuretic peptide system,atrial natriuretic peptide and brain natriuretic peptide.J Clin Invest,1991,87:1402-1412.
  • 5McCullough PA,Omland T,Maisel AS.B-type natriuretic peptides:a diagnostic breakthrough for clinicians.Rev Cardiovasc Med,2003,4:72-80.
  • 6Shapiro BP,Chen HH,Burnett JC Jr,et al.Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure.Mayo Clin Proc,2003,78:481-486.
  • 7Tjeerdsma G,de Boer RA,Boomsma F,et al.Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure.Int J Cardiol,2002,86:143-152.
  • 8Latini R,Masson S,de Angelis N,et al.Role of brain natriuretic peptide in the diagnosis and management of heart failure:current concepts.J Card Fail,2002,8:288-299.
  • 9Logeart D.Ultra-rapid measurement of brain natriuretic peptide.Arch Mal Coeur Vaiss,2002,95:185-188.
  • 10Peacock WF 4th.The B-type natriuretic peptide assay:a rapid test for heart failure.Cleve Clin J Med,2002,69:243-251.

二级参考文献24

  • 1[1]Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult--summary article[J].Circulation,2005,112(12):1825-1852.
  • 2[2]Khand A,Gemmel I,Clark A,et al.Is the prognosis of heart failure improving?[J].J Am Coll Cardiol,2000,36(7):2284-2286.
  • 3[3]Cleland JG,Swedberg K,Follath F,et al.The Euro Heart Failure survey programme:survey on the quality of care among patients with heart failure in Europe.Part I:patient characteristics and diagnosis[J].Eur Heart J,2003,24(5):442-463.
  • 4[4]He J,Gu D,Wu X,et al.Major causes of death among men and women in China[J].N Engl J Med,2005;353(11):1124-1134.
  • 5[6]Sliwa K,Woodiwiss A,Kone VN,et al.Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline.Results of a randomized study[J].Circulation,2004,109(6):750-755.
  • 6[7]Rizzello V,Poldermans D,Boersma E,et al.Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy.Role of myocardial viability[J].Circulation,2004,110(16):2383-2388.
  • 7[8]Chareonthaitawee P,Gersh B,Araoz PA,et al.Revascularization in severe left ventricular dysfunction.The role of viability testing[J].J Am Coll Cardiol,2005,46(4):567-574.
  • 8[9]Knuuti J,Schelbert HR,Bax JJ.The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischemic left ventricular dysfunction[J].Eur J Nucl Med Imaging,2002,29(9):1257-1266.
  • 9[10]Zoghbi WA.Evaluation of myocardial viability with contrast echocardiography[J].Am J Cardiol,2002,90(10A):65J~71J.
  • 10[11]Wu KC,Lima JA.Noninvasive imaging of myocardial viability:current techniques and future developments[J].Circulation,2003,93(12):1146-1158.

共引文献9

同被引文献26

  • 1Januzzi J L Jr,Bamberg F,Lee H,et el.High-sensitivity troponin Z concentrations in acute chest pain patients evaluated with cardiac computed tomography.Circulation,2010,121:1227-1234.
  • 2Kavsak P A,Wang X,Ko D T,et al.Short-and long-term risk stratification using a next-generation,high-sensitivity research cardiac troponin I(hs-cTnⅠ)assay in an emergency department chest pain population.Clin Chem,2009,55:1809-1815.
  • 3Eggers K M,Lagerqvist B,Venge P,et al.Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.J Am Coll Cardiol,2009,54:357-364.
  • 4Eggers K M,Lind L,Ahlstr(o)m H,et al.Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.Eur Heart J,2008,29:2252-2258.
  • 5Giannitsis E,Katus H A.Troponins and high-sensitivity troponins as markers of necrosis in CAD and heart failure.Herz,2009,34:600-666.
  • 6Schulz O,Reinicke M,Berghoefer G H,et al.High-sensitive cardiac troponin I(hs-cTnⅠ)values in patients with stable cardiovascular disease:an initial foray.Clin Chim Acta,2010,411:812-817.
  • 7Omland T,de Lemos J A,Sabatine M S,et al.A sensitive cardiac troponin T assay in stable coronary artery disease.N Engl J Med,2009,361:2538-2547.
  • 8Latini R,Masson S.Biomarkers of myocyte injury in heart failure.Heart Fail Clin,2009,5:529-536.
  • 9Latini R,Masson S,Anand I S,et al.Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.Circulation,2007,116:1242-1249.
  • 10Clerico A,Giannoni A,Prontera C,et el.High-sensitivity troponin:a new tool for pathophysiological investigation and clinical practice.Adv Clin Chem,2009,49:1-30.

引证文献1

二级引证文献12

上海医学
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部